These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21234261)

  • 1. State of the art in intravesical therapy for lower urinary tract symptoms.
    Kaufman J; Tyagi V; Anthony M; Chancellor MB; Tyagi P
    Rev Urol; 2010; 12(4):e181-9. PubMed ID: 21234261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical drug delivery for dysfunctional bladder.
    Hsu CC; Chuang YC; Chancellor MB
    Int J Urol; 2013 Jun; 20(6):552-62. PubMed ID: 23336527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in intravesical therapy for urinary tract disorders.
    Tyagi P; Kashyap M; Hensley H; Yoshimura N
    Expert Opin Drug Deliv; 2016; 13(1):71-84. PubMed ID: 26479968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.
    Tyagi P; Kashyap MP; Kawamorita N; Yoshizawa T; Chancellor M; Yoshimura N
    ISRN Pharmacol; 2014; 2014():601653. PubMed ID: 24527221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis.
    Zhang W; Deng X; Liu C; Wang X
    Int Urogynecol J; 2017 Apr; 28(4):515-525. PubMed ID: 27614759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
    Dawson TE; Jamison J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial cystitis intravesical therapy.
    Ha T; Xu JH
    Transl Androl Urol; 2017 Jul; 6(Suppl 2):S171-S179. PubMed ID: 28791236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical liposome drug delivery and IC/BPS.
    Janicki JJ; Gruber MA; Chancellor MB
    Transl Androl Urol; 2015 Oct; 4(5):572-8. PubMed ID: 26816855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Therapy with Intravesical Liposomes for Ulcerative Interstitial Cystitis/Painful Bladder Syndrome.
    Peters KM; Hasenau DL; Anthony M; Kaufman J; Killinger KA
    Low Urin Tract Symptoms; 2012 Jan; 4(1):51-3. PubMed ID: 26676460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2012 Feb; 66(2):146-51. PubMed ID: 21951755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
    Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical glycosaminoglycans in the management of chronic cystitis.
    Iacovelli V; Topazio L; Gaziev G; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nefrol; 2013 Dec; 65(4):249-62. PubMed ID: 24091478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases.
    Sarfraz M; Qamar S; Rehman MU; Tahir MA; Ijaz M; Ahsan A; Asim MH; Nazir I
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review.
    Bogart LM; Berry SH; Clemens JQ
    J Urol; 2007 Feb; 177(2):450-6. PubMed ID: 17222607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
    Chuang YC; Chermansky C; Kashyap M; Tyagi P
    Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.